Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Retrophin Inc (NASDAQ:RTRX)

23.64
Delayed Data
As of Aug 17
 +0.37 / +1.59%
Today’s Change
15.55
Today|||52-Week Range
24.57
+24.88%
Year-to-Date

Today’s Trading

Previous close23.27
Today’s open23.25
Day’s range23.25 - 23.73
Volume585,748
Average volume (3 months)284,266
Market cap$907.4M
Dividend yield--
Data as of 08/17/2017

Growth & Valuation

Earnings growth (last year)-140.69%
Earnings growth (this year)+11.63%
Earnings growth (next 5 years)+137.00%
Revenue growth (last year)+33.74%
P/E ratioNM
Price/Sales5.43
Price/Book2.91

Competitors

 Today’s
change
Today’s
% change
SGMOSangamo Therapeutics...-0.35-3.30%
EPZMEpizyme Inc+0.25+1.81%
FPRXFive Prime Therapeut...-0.01-0.04%
NDRMNeuroderm Ltd-0.10-0.26%
Data as of 08/17/2017

Financials

Next reporting dateNovember 20, 2017
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$133.6M
Annual profit (last year)-$47.9M
Net profit margin-35.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen J. Aselage
Chief Operating Officer
Neil McFarlane
Corporate headquarters
San Diego, California

Forecasts